All.Can around the world

All.Can Poland

Cancer care in Poland

Compared to other European Union countries, both health spending in general and spending on cancer care in Poland (by percentage of GDP per capita) are very low. Despite improvements in recent years, Poland still has much lower survival rates for most types of cancer than other EU countries.

All.Can Poland initiative

To this context, Poland launched the All.Can initiative in 2017 with the aim to improve efficiency in cancer care on a national level and to close existing gaps in care.

The Polish All.Can multi-stakeholder group is made up of Polish experts in the field of cancer care and public health, and representatives of patient organisations and industry. The All.Can Poland initiative was officially launched on 21 March 2017.

Key milestones and successes

All.Can Poland has made some crucial steps in promoting the aims of All.Can through the following activities:

Disclaimer:

The All.Can initiative is made up of leading representatives of patient organisations, policy makers, health care professionals, science and industry. All the publications produced under the initiative reflect the consensus of All.Can members who have full editorial control. The All.Can initiative in Poland was created with the financial support of Bristol-Myers Squibb (the main sponsor) and Amgen, MSD, Novartis, Pfizer and Roche. None of the content developed in discussions and activities of the All.Can initiative contains direct or indirect references to specific medicinal products or therapies. All.Can is a trademark of The Health Policy Partnership Limited.

Steering group

Prof. Jacek Fijuth

Prof. Jacek Fijuth

President of the Polish Oncology Society

Prof. Jacek Jassem

Prof. Jacek Jassem

Medical University of Gdansk

Prof. Maciej Krzakowski

Prof. Maciej Krzakowski

Warsaw Oncology Center, national consultant on clinical oncology

Prof. Zbigniew Nowecki

Prof. Zbigniew Nowecki

Warsaw Oncology Center, specialist in breast cancer

Prof. Rodryg Ramlau

Prof. Rodryg Ramlau

Medical University of Poznan

Prof. Piotr Rutkowski

Prof. Piotr Rutkowski

Warsaw Oncology Center, specialist in melanoma

Prof. Krzysztof Składowski

Prof. Krzysztof Składowski

Oncology Center, Gliwice

Prof. Piotr Wysocki

Prof. Piotr Wysocki

President of the Polish Society of Clinical Oncology

Dr Joanna Didkowska

Dr Joanna Didkowska

National Cancer Register

Dr Urszula Wojciechowska

Dr Urszula Wojciechowska

National Cancer Register

Małgorzata Gałązka-Sobotka

Małgorzata Gałązka-Sobotka

PhD – health economist, Lazarski University

Kamil Dolecki

Kamil Dolecki

President of the patient association “Sarcoma”

Elzbieta Kozik

Elzbieta Kozik

President of the Polish Amazons Social Movement

Elzbieta Majewska

Elzbieta Majewska

Polish Amazons Social Movement

Barbara Pepke

Barbara Pepke

President of the foundation “Star of Hope”

Ewelina Szmytke

Ewelina Szmytke

Association for Fight Against Lung Cancer

Magdalena Zmyslowska

Magdalena Zmyslowska

Polish League Against Cancer

Małgorzata Dziak-Masny

Małgorzata Dziak-Masny

Representative of the Melanoma Academy

Elżbieta Łapot

Elżbieta Łapot

Market Access Manager Oncology, Bristol-Myers Sqiubb

Supporting members

Bartosz Poliński

Bartosz Poliński

Fundacja Onkologiczna Osób Młodych Alivia

Joanna Rokoszewska-Łojko

Joanna Rokoszewska-Łojko

Fundacja Rak’n’roll Wygraj Życie

Karol Poznański

Karol Poznański

MSD

Jacek Graliński

Jacek Graliński

Amgen

Izabella Dessoulavy-Gładysz

Izabella Dessoulavy-Gładysz

Roche

Aneta Poznańska

Aneta Poznańska

Novartis

Aldona Zygmunt

Aldona Zygmunt

Pfizer

Secretariat

Sekretariat

Sekretariat

Rohde Public Policy (RPP Group)

Publications

All.Can Poland Report

The describes the state of cancer care in Poland and the recommendations reflect the consensus of Polish experts in the field of cancer care and public health, representatives of patient organizations and industry, who are part of the Polish Steering Group, established within the framework of the international All.Can project.

The key message of the report is the need for more efficient budget management through better allocation of resources for cancer care. The report affirms it will be possible to improve outcomes for patients using the available resources, while maintaining that the achievement of expected performance indicators in the long-term will require increased investment. It put forward the following core objectives and recommendations for improving efficiency and sustainability of cancer care in Poland:

  • Improving the allocation of available resources for cancer care
  • Increasing the role of primary prevention and screening
  • Ensuring faster and broader access to innovative health technologies
  • Considering the perspective of patients in all decisions related to the process of planning, implementation and evaluation of cancer care
  • Improving patient access to clinical trials.
Read the full report